calamine lotion 11.25%, 8%
شـركــة فيلادلـفيا لــصناعـــة الأدويـــــــة - philadelphia pharmaceuticals - calamine 11.25 %, zinc oxide 8 % - 11.25%, 8%
calamine lotion 11.25%, 5%
شـركــة فيلادلـفيا لــصناعـــة الأدويـــــــة - philadelphia pharmaceuticals - calamine 11.25 %, zinc oxide 5 % - 11.25%, 5%
calamine plus lotion 11.25%, 0.1%, 0.1%, 8%
شـركــة فيلادلـفيا لــصناعـــة الأدويـــــــة - philadelphia pharmaceuticals - calamine 11.25 %, camphor 0.1 %, menthol 0.1 %, zinc oxide 8 % - 11.25%, 0.1%, 0.1%, 8%
prostap 11.25 milligram pdr+solv for susp for inj
takeda uk limited - leuprorelin acetate - pdr+solv for susp for inj - 11.25 milligram - gonadotropin releasing hormone analogues
diphereline p.r. powder and solvent for suspension for injection 11.25 mgvial
ipsen pharma singapore pte. ltd. - triptorelin pamoate eqv. triptorelin - injection, powder, for suspension, extended release - 11.25 mg/vial - triptorelin pamoate eqv. triptorelin 11.25 mg/vial
decapeptyl 3-month, 11.25 mgpowder and solvent for suspension for injection
ipsen pharmaceuticals limited - triptorelin - powder and solvent for suspension for injection - 11.25 milligram(s) - gonadotropin releasing hormone analogues; triptorelin
prostap 3, 11.25 mg, powder and solvent for prolon 11.25 milligram pdr+solv for susp for inj
takeda uk limited - leuprorelin acetate - pdr+solv for susp for inj - 11.25 milligram
prostap 3 11.25 milligram pdr+solv for susp for inj
pco manufacturing - leuprorelin acetate - pdr+solv for susp for inj - 11.25 milligram
scholl corn and callous removal liquid 11.25/2.8 %w/v cutaneous solution
scholl consumer products limited - salicylic acid camphor - cutaneous solution - 11.25/2.8 %w/v
tulissin 25- tulathromycin injection, solution
virbac ah, inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - swine tulissin 25 injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, bordetella bronchiseptica, haemophilus parasuis, and mycoplasma hyopneumoniae ; and for the control of srd associated with actinobacillus pleuropneumoniae, pasteurella multocida, and mycoplasma hyopneumoniae in groups of pigs where srd has been diagnosed. suckling calves, dairy calves, and veal calves brd - tulissin 25 injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni, and mycoplasma bovis. the use of tulissin 25 injectable solution is contraindicated in animals previously found to be hypersensitive to the drug. residue warnings swine swine intended for human consumption must not be slaughtered within 5 days from the last treatment. calves calves intended for human consumption must not be slaughtered within 22